Effects of WB-EMS and Protein Supplementation on LBM Maintenance During Intended Weight Loss
Effects of Whole-body Electromyostimulation (WB-EMS), Physical Activity and Protein Supplementation on Lean Body Mass Maintenance During Caloric Restriction and Physical Activity Induced Weight Loss. A Randomized Controlled Study
1 other identifier
interventional
30
1 country
1
Brief Summary
The present study aimed to determine the effect of different interventions on lean body mass maintenance under weight loss conditions in overweight and obese premenopausal women. Three study groups were implemented: (1) Protein supplementation (only) group (2) Protein supplementation and walking intervention (3) Protein supplementation, walking and WB-EMS-application. All protocols were applied for 16 week of intervention. A energy deficit of 500 kcal/d was intended however while group (1) focus consistently on energy restriction (500 kcal/d), in group (2) and (3) a combined physical activity (i.e. walking with a volume representing 250 kcal/d) and energy restriction (250 kcal/d) protocol was applied. Total protein uptake including protein supplementation was calculated to average around 1.2 g/kg body mass per day in groups (1) and 1.5 g/kg body mass/d in group (2) and (3). WB-EMS was applied 1.5x 20 min/week (i.e. each Tuesday and every second Thursday). Primary study endpoint was LBM as determined by Dual Energy x-Ray Absorptiometry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 25, 2018
CompletedFirst Submitted
Initial submission to the registry
November 13, 2018
CompletedFirst Posted
Study publicly available on registry
November 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedMarch 18, 2019
March 1, 2019
10 months
November 13, 2018
March 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lean body mass
Fat and bone free total body mass in kg
changes from baseline to 16 week follow-up
Secondary Outcomes (6)
Total Body Fat
changes from baseline to 16 week follow-up
Total Body Fat Rate
changes from baseline to 16 week follow-up
Appendicular Skeletal Muscle Mass
changes from baseline to 16 week follow-up
Visceral Body Fat
changes from baseline to 16 week follow-up
Trunk fat
changes from baseline to 16 week follow-up
- +1 more secondary outcomes
Study Arms (3)
energy restriction and protein supplementation
ACTIVE COMPARATOREnergy restriction of 500 kcal/d and total Protein Uptake (including Supplementation) of 1.2 g/kg body mass/d
Energy restriction, walking and protein
ACTIVE COMPARATOREnergy restriction of 250 kcal/d, increased energy consumption by walking (250 kcal/d) and total protein uptake (including supplementation) of 1.5 g/kg body mass/d
Energy restriction, walking, protein and WB-EMS
ACTIVE COMPARATOREnergy restriction of 250 kcal/d, increased energy consumption by walking (250 kcal/d), total protein uptake (including supplementation) of 1.5 g/kg body mass/d and WB-EMS application 1,5x 20 min/week
Interventions
Protein supplementation 1.2 or 1.5 g/kg body mass/d
Walking with a volume corresponding to 250 kcal/d
WB-EMS application 1.5x 20 min/week
Eligibility Criteria
You may qualify if:
- premenopausal women 25-50 years old
- overweight/obesity (body fat rate equal or higher 30%)
You may not qualify if:
- medication and diseases affecting muscle and fat metabolism
- pregnant or parturition \< 6 months
- any condition or medication that prevent proper physical activity or WB-EMS application
- holidays equal or more than 1 week during the intervention period
- other interventions with impact on the primary and core secondary outcome (i.e. body fat parameters) started during the last year.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Medical Physics University of Erlangen-Nurnberg
Erlangen, 91052, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Simon von Stengel, PhD
Institute of Medical Physics, FAU Erlangen-Nürnberg, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors were not aware of the status of the participants and were not allowed to ask correspondingly. Each of the participants were blinded according to the treatment and intervention. Participants of the three study groups were not in contact.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Dr. Wolfgang Kemmler, Principal Investigator
Study Record Dates
First Submitted
November 13, 2018
First Posted
November 20, 2018
Study Start
January 25, 2018
Primary Completion
November 30, 2018
Study Completion
December 1, 2018
Last Updated
March 18, 2019
Record last verified: 2019-03